Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

4.9%

45 terminated/withdrawn out of 922 trials

Success Rate

94.2%

+7.7% vs industry average

Late-Stage Pipeline

17%

160 trials in Phase 3/4

Results Transparency

18%

128 of 730 completed trials have results

Key Signals

47 recruiting128 with results26 terminated19 withdrawn

Enrollment Performance

Analytics

N/A
464(59.9%)
Phase 4
106(13.7%)
Phase 2
84(10.9%)
Phase 1
66(8.5%)
Phase 3
54(7.0%)
774Total
N/A(464)
Phase 4(106)
Phase 2(84)
Phase 1(66)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (922)

Showing 20 of 922 trials
NCT01243437Phase 2Completed

A Clinical Trial to Evaluate the Safety and Efficacy of Ciprofloxacin in the Treatment of Plague in Humans

Role: lead

NCT01044199Not ApplicableCompleted

Study of Intradermal Administration of PCEC Rabies Vaccine

Role: lead

NCT03474029Phase 2Recruiting

Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI

Role: lead

NCT05835206Phase 2Recruiting

Further MT for Antibiotic-Resistant Bacterial Colonization

Role: collaborator

NCT03730181Phase 1Completed

Tuberculosis Clinical Trials Consortium Study 35

Role: lead

NCT06045923Terminated

Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV

Role: lead

NCT00448981Not ApplicableCompleted

Stopping Upper Respiratory Infections and Flu in the Family: The Stuffy Trial

Role: lead

NCT07287137Phase 4Active Not Recruiting

Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study

Role: collaborator

NCT06545656Phase 4Completed

Daily Doxycycline to Inform Sexually Transmitted Infection Prophylaxis Regimens

Role: collaborator

NCT06488846Enrolling By Invitation

Innovative Administration of Long-Acting Injectables for HIV Treatment Enhancement at Home

Role: collaborator

NCT05212792Recruiting

Genomics and COVID-19 Vaccine Adverse Events

Role: collaborator

NCT06176300Not ApplicableEnrolling By Invitation

Evaluation of Violence Prevention Strategies to Prevent and Reduce Community Levels of Youth Violence

Role: collaborator

NCT05821205Not ApplicableCompleted

Michigan Youth Violence Prevention Center: Building Evidence for Gun Violence Prevention - SafERteens Implementation

Role: collaborator

NCT05052502Not ApplicableCompleted

Targeting High Risk Populations With Enhanced Reactive Focal Mass Drug Administration in Thailand

Role: collaborator

NCT01772602Recruiting

The National Amyotrophic Lateral Sclerosis Registry

Role: lead

NCT04416945Not ApplicableWithdrawn

Targeting High Risk Populations With Enhanced Reactive Case Detection in Southern Lao Peoples Democratic Republic

Role: collaborator

NCT05109325Not ApplicableCompleted

Project IntERact V2

Role: collaborator

NCT02977715Phase 3Completed

JYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the Congo

Role: lead

NCT04793750Not ApplicableCompleted

Ending the HIV Epidemic Through Point-of-Care Technologies (EHPOC)

Role: collaborator

NCT06693778Active Not Recruiting

Utilizing Electronic Clinical Decision Support to Enhance mTBI Care at the Primary Care Point of Entry

Role: collaborator